1
|
Fortuna K, Mbao M, Kadakia A, Myers A, Fischer D, MacDonald S, Brunchet S, Hintz I, Rossom R, Brooks J, Kalisa J, Haragirimana C, Storm M, Mois G, Umucu E, Almeida M, Rivera J, Zisman Ilani Y, Venegas M, Walker R. Peer and Non-Peer Academic Scientists and Peer Support Specialist Community of Practice: Stakeholder Engagement to Advance the Science of Peer Support. PROCEEDINGS. IEEE GLOBAL HUMANITARIAN TECHNOLOGY CONFERENCE 2021; 2021:188-194. [PMID: 35498510 PMCID: PMC9053294 DOI: 10.1109/ghtc53159.2021.9612411] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 04/28/2023]
Abstract
Community of Practice, a community-engagement method that encourages a group of people to interact regularly towards a common goal, may promote satisfying experiences in patient-outcomes research among marginalized populations. Peer support specialists are increasingly being involved in peer-informed mental health research due to their lived experiences of mental illness and are an asset in co-designing healthcare programs along with researchers. In 2015, ten scientists and ten mental health service users joined as a Community of Practice that trained to engage in patient-centered outcomes research. The group has so far has presented at 20 conferences, published three book chapters and 30 peer-reviewed publications, and developed two smartphone applications. Of note are the co-production of a smartphone application, a digital peer support certification program, an app decision support tool, and an instrument to assess the value of patient-research partnerships. Future research will assess the feasibility of incorporating more stakeholders to enhance research outcomes.
Collapse
Affiliation(s)
- Karen Fortuna
- Geisel School of Medicine, Dartmouth College, Hanover NH, USA
| | | | | | | | | | - Sandi MacDonald
- International Association of Pre-Menstrual Disorders, Nova Scotia, CA
| | - Sheila Brunchet
- International Association of Pre-Menstrual Disorders, Nova Scotia, CA
| | | | | | | | | | | | - Marianne Storm
- University of Stavanger & Molde University College, Norway
| | | | - Emre Umucu
- University of Texas at El Paso, El Paso TX, USA
| | | | | | | | | | | |
Collapse
|
2
|
Benson P, Power T, Agudera F, Hayes C. Cocreating Programmable Diagnostic Simulation: Devices to Enhance Reality in Vital Sign Measurement. J Nurs Educ 2021; 60:235-239. [PMID: 34038280 DOI: 10.3928/01484834-20210322-10] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Abstract
BACKGROUND Providing authentic educational experiences in clinical teaching laboratories or health care simulation environments is fundamental to producing optimum learning. However, some simulated diagnostic devices are price prohibitive or yet to be developed. This article explores a collaborative effort between health academics and engineering interns to develop cost-effective, authentic devices that overcome limitations of those currently available. METHOD Simulated patient tympanic thermometer and pulse oximetry devices were developed for use in clinical teaching laboratories and health care simulation environments. RESULTS The tympanic thermometers and pulse oximetry probes provide programmable temperature, pulse, and oxygen saturation for use with any commercially available manikins or standardized patients. CONCLUSION Authentic simulated diagnostic devices can enhance reality and foster immersion in clinical simulation scenarios. Sharing cost-effective innovations designed to address the simulation-specific limitations of commercially available diagnostic devices provides health care educators with solutions that can enhance the authenticity of clinical teaching experiences for participants. [J Nurs Educ. 2021;60(4):235-239.].
Collapse
|
3
|
Sultan S, Parodi J, Acharya Y, Hynes N. Why Are Medical Device Multinationals Choking Disruptive Technology and Killing Innovation? Challenges to Innovation in Medical Device Technology. J Endovasc Ther 2021; 28:367-372. [PMID: 33511910 DOI: 10.1177/1526602821989356] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Affiliation(s)
- Sherif Sultan
- Department of Vascular and Endovascular Surgery, Western Vascular Institute, University Hospital Galway, National University of Ireland, Galway, Ireland.,Department of Vascular Surgery and Endovascular Surgery, Galway Clinic, Affiliated Hospital of the Royal College of Surgeons in Ireland and the National University of Ireland, Doughiska Galway, Ireland
| | - Juan Parodi
- Department of Vascular Surgery and Biomedical Engineering Department, Alma Mater, University of Buenos Aires, and Trinidad Hospital, San Isidro, Buenos Aires, Argentina.,Wake Forest University, Winston-Salem, NC, USA.,Washington University in St Louis, St Louis, MO, USA
| | - Yogesh Acharya
- Department of Vascular and Endovascular Surgery, Western Vascular Institute, University Hospital Galway, National University of Ireland, Galway, Ireland.,Department of Vascular Surgery and Endovascular Surgery, Galway Clinic, Affiliated Hospital of the Royal College of Surgeons in Ireland and the National University of Ireland, Doughiska Galway, Ireland
| | - Niamh Hynes
- Department of Vascular Surgery and Endovascular Surgery, Galway Clinic, Affiliated Hospital of the Royal College of Surgeons in Ireland and the National University of Ireland, Doughiska Galway, Ireland
| |
Collapse
|
4
|
Ford KL, Leiferman J, Sobral B, Bennett JK, Moore SL, Bull S. "It depends:" a qualitative study on digital health academic-industry collaboration. Mhealth 2021; 7:57. [PMID: 34805388 PMCID: PMC8572752 DOI: 10.21037/mhealth-20-140] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/11/2020] [Accepted: 02/07/2021] [Indexed: 11/06/2022] Open
Abstract
BACKGROUND Academic-industry collaborations (AICs) are endorsed to alleviate challenges in digital health, but partnership experiences remain understudied. The qualitative study's objective investigated collaboration experiences between academic institutions and digital health companies. METHODS A phenomenology methodology captured experiences of AICs, eliciting perspectives from academic researchers and industry affiliates (e.g., leadership, company investigators). Semi-structured interviews probed eligible collaborators about their experiences in digital health. Analysts coded and organized data into significant statements reaching thematic saturation. RESULTS Participants (N=20) were interviewed from 6 academic institutions and 14 unique industry partners. Seven themes emerged: (I) Collaboration evolves with time, relationships, funding, and evidence; (II) Collaboration demands strong relationships and interpersonal dynamics; (III) Operational processes vary across collaborations; (IV) Collaboration climate and context matters; (V) Shared expectations lead to a better understanding of success; (VI) Overcoming challenges with recommendations; (VII) Collaboration may help navigate the global pandemic. CONCLUSIONS Digital health academic industry collaboration demands strong relationships, requiring flexible mechanisms of collaboration and cultural fit. Diverse models of collaboration exist and remain dependent on contextual factors. While no collaboration conquers all challenges in digital health, AICs may serve as a facilitator for improved digital health products, thus advancing science, promoting public health, and benefiting the economy.
Collapse
Affiliation(s)
- Kelsey L. Ford
- Colorado School of Public Health, University of Colorado, Aurora, CO, USA
| | - Jenn Leiferman
- Colorado School of Public Health, University of Colorado, Aurora, CO, USA
| | - Bruno Sobral
- Colorado School of Public Health, University of Colorado, Aurora, CO, USA
- Colorado State University, Fort Collins, CO, USA
| | - John K. Bennett
- University of Colorado Denver, Denver, CO, USA
- University of Colorado Boulder, Boulder, CO, USA
| | - Susan L. Moore
- Colorado School of Public Health, University of Colorado, Aurora, CO, USA
| | - Sheana Bull
- Colorado School of Public Health, University of Colorado, Aurora, CO, USA
- University of Colorado Denver, Denver, CO, USA
| |
Collapse
|
5
|
Abstract
Vascular surgery is a specialty discipline highlighted by a lifelong learning process from which new endovascular devices and techniques will continue to emerge. Industry partnerships can provide a safe learning environment for trainees, with a focus on maximizing learning opportunities during fellowship or residency. Unlike other surgical specialties, vascular surgery empowers its trainees to become competent in both open and image-guided endovascular interventions, requiring two unique skill sets to become a contemporary vascular surgeon. Due to the rapid growth of technology and innovations, industry partnerships enhance and maximize the learning experience of the trainee by often providing the products, education, research support, and financial assistance. This can come in the form of innovative and educational activities, including simulation, exposure to thought leaders, attendance at conferences and workshops, and one-on-one assistance with cases. In this article, we review the role that industry can serve in vascular education to support budding vascular surgeons through exposure and repetition as they lay down the fundamentals of their careers.
Collapse
Affiliation(s)
- Anahita Dua
- Division of Vascular Surgery, Stanford Hospitals and Clinic, Stanford, CA
| | - Kara Rothenberg
- Division of Vascular Surgery, Stanford Hospitals and Clinic, Stanford, CA
| | - Jason T Lee
- Division of Vascular Surgery, Stanford Hospitals and Clinic, Stanford, CA.
| |
Collapse
|
6
|
Sheridan DC, Ma OJ, Hansen ML. Emergency physicians can be leaders in clinical innovation: Tips to JumpStart the engine. Am J Emerg Med 2018; 37:1198-1199. [PMID: 30366743 DOI: 10.1016/j.ajem.2018.10.037] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/18/2018] [Revised: 10/18/2018] [Accepted: 10/18/2018] [Indexed: 11/18/2022] Open
Affiliation(s)
- David C Sheridan
- Department of Emergency Medicine, Oregon Health & Science University, United States of America.
| | - O John Ma
- Department of Emergency Medicine, Oregon Health & Science University, United States of America
| | - Matthew L Hansen
- Department of Emergency Medicine, Oregon Health & Science University, United States of America
| |
Collapse
|
7
|
Cremer ML, Conzuelo-Rodriguez G, Cherniak W, Randall T. Ablative Therapies for Cervical Intraepithelial Neoplasia in Low-Resource Settings: Findings and Key Questions. J Glob Oncol 2018; 4:1-10. [PMID: 30372399 PMCID: PMC7010451 DOI: 10.1200/jgo.18.00093] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/19/2022] Open
Abstract
Barriers to access for cervical precancer care in low-resource settings go beyond cost. Gas-based cryotherapy has emerged as the standard treatment in these areas, but there are barriers to this technology that have necessitated the development and implementation of affordable and portable alternatives. This review identifies knowledge gaps with regard to technologies primarily used in low-resource settings, including standard cryotherapy, nongas-based cryotherapy, and thermoablation. These gaps are addressed using evidence-based guidelines, patient and provider acceptability, long-term obstetric outcomes, and treatment of women with HIV infection. This review highlights the need for prospective studies that compare ablative methods, especially given the increasing use of thermoablation.
Collapse
Affiliation(s)
- Miriam L. Cremer
- Miriam L. Cremer, Cleveland Clinic, Cleveland, OH; Gabriel Conzuelo-Rodriguez, Basic Health International, New York, NY; William Cherniak, Bridge to Health Medical and Dental, Toronto, Ontario, Canada; and Thomas Randall, Massachusetts General Hospital, Boston, MA
| | - Gabriel Conzuelo-Rodriguez
- Miriam L. Cremer, Cleveland Clinic, Cleveland, OH; Gabriel Conzuelo-Rodriguez, Basic Health International, New York, NY; William Cherniak, Bridge to Health Medical and Dental, Toronto, Ontario, Canada; and Thomas Randall, Massachusetts General Hospital, Boston, MA
| | - William Cherniak
- Miriam L. Cremer, Cleveland Clinic, Cleveland, OH; Gabriel Conzuelo-Rodriguez, Basic Health International, New York, NY; William Cherniak, Bridge to Health Medical and Dental, Toronto, Ontario, Canada; and Thomas Randall, Massachusetts General Hospital, Boston, MA
| | - Thomas Randall
- Miriam L. Cremer, Cleveland Clinic, Cleveland, OH; Gabriel Conzuelo-Rodriguez, Basic Health International, New York, NY; William Cherniak, Bridge to Health Medical and Dental, Toronto, Ontario, Canada; and Thomas Randall, Massachusetts General Hospital, Boston, MA
| |
Collapse
|
8
|
Beswick DM, Kaushik A, Beinart D, McGarry S, Yew MK, Kennedy BF, Maria PLS. Biomedical device innovation methodology: applications in biophotonics. JOURNAL OF BIOMEDICAL OPTICS 2017; 23:1-7. [PMID: 29243414 DOI: 10.1117/1.jbo.23.2.021102] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/11/2017] [Accepted: 11/15/2017] [Indexed: 05/03/2023]
Abstract
The process of medical device innovation involves an iterative method that focuses on designing innovative, device-oriented solutions that address unmet clinical needs. This process has been applied to the field of biophotonics with many notable successes. Device innovation begins with identifying an unmet clinical need and evaluating this need through a variety of lenses, including currently existing solutions for the need, stakeholders who are interested in the need, and the market that will support an innovative solution. Only once the clinical need is understood in detail can the invention process begin. The ideation phase often involves multiple levels of brainstorming and prototyping with the aim of addressing technical and clinical questions early and in a cost-efficient manner. Once potential solutions are found, they are tested against a number of known translational factors, including intellectual property, regulatory, and reimbursement landscapes. Only when the solution matches the clinical need, the next phase of building a "to market" strategy should begin. Most aspects of the innovation process can be conducted relatively quickly and without significant capital expense. This white paper focuses on key points of the medical device innovation method and how the field of biophotonics has been applied within this framework to generate clinical and commercial success.
Collapse
Affiliation(s)
- Daniel M Beswick
- Stanford University, Department of Otolaryngology, Head and Neck Surgery, Stanford, California, United States
- Oregon Health and Science University, Department of Otolaryngology, Head and Neck Surgery, Portland,, United States
| | - Arjun Kaushik
- SPARK Co-Lab, Perth, Western Australia, Australia
- Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia
| | - Dylan Beinart
- SPARK Co-Lab, Perth, Western Australia, Australia
- Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia
| | - Sarah McGarry
- SPARK Co-Lab, Perth, Western Australia, Australia
- Curtin University, School of Occupational Therapy and Social Work, Faculty of Health Sciences, Bentl, Australia
| | - Ming Khoon Yew
- SPARK Co-Lab, Perth, Western Australia, Australia
- Royal Perth Hospital, Department of General Surgery, Perth, Western Australia, Australia
| | - Brendan F Kennedy
- QEII Medical Centre, Harry Perkins Institute of Medical Research, BRITElab, Nedlands, Western Austra, Australia
- University of Western Australia, Centre for Medical Research, Perth, Western Australia, Australia
- University of Western Australia, School of Electrical, Electronic and Computer Engineering, Perth, W, Australia
| | - Peter Luke Santa Maria
- Stanford University, Department of Otolaryngology, Head and Neck Surgery, Stanford, California, United States
- SPARK Co-Lab, Perth, Western Australia, Australia
- University of Western Australia, Department of Ear Sciences, Perth, Western Australia, Australia
| |
Collapse
|
9
|
Haney K, Tandon P, Divi R, Ossandon MR, Baker H, Pearlman PC. The Role of Affordable, Point-of-Care Technologies for Cancer Care in Low- and Middle-Income Countries: A Review and Commentary. IEEE JOURNAL OF TRANSLATIONAL ENGINEERING IN HEALTH AND MEDICINE-JTEHM 2017; 5:2800514. [PMID: 29204328 PMCID: PMC5706528 DOI: 10.1109/jtehm.2017.2761764] [Citation(s) in RCA: 17] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 07/31/2017] [Accepted: 09/06/2017] [Indexed: 12/22/2022]
Abstract
As the burden of non-communicable diseases such as cancer continues to rise in low- and middle-income countries (LMICs), it is essential to identify and invest in promising solutions for cancer control and treatment. Point-of-care technologies (POCTs) have played critical roles in curbing infectious disease epidemics in both high- and low-income settings, and their successes can serve as a model for transforming cancer care in LMICs, where access to traditional clinical resources is often limited. The versatility, cost-effectiveness, and simplicity of POCTs warrant attention for their potential to revolutionize cancer detection, diagnosis, and treatment. This paper reviews the landscape of affordable POCTs for cancer care in LMICs with a focus on imaging tools, in vitro diagnostics, and treatment technologies and aspires to encourage innovation and further investment in this space.
Collapse
Affiliation(s)
- Karen Haney
- Dell Medical SchoolThe University of Texas at Austin
| | | | | | | | | | | |
Collapse
|
10
|
Development of enhanced ethanol ablation as an alternative to surgery in treatment of superficial solid tumors. Sci Rep 2017; 7:8750. [PMID: 28821832 PMCID: PMC5562881 DOI: 10.1038/s41598-017-09371-2] [Citation(s) in RCA: 30] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/05/2017] [Accepted: 07/27/2017] [Indexed: 12/11/2022] Open
Abstract
While surgery is at the foundation of cancer treatment, its access is limited in low-income countries. Here, we describe development of a low-cost alternative therapy based on intratumoral ethanol injection suitable for resource-limited settings. Although ethanol-based tumor ablation is successful in treating hepatocellular carcinomas, the necessity for multiple treatments, injection of large fluid volumes, and decreased efficacy in treatment of non-capsulated tumors limit its applicability. To address these limitations, we investigated an enhanced ethanol ablation strategy to retain ethanol within the tumor through the addition of ethyl cellulose. This increases the viscosity of injected ethanol and forms an ethanol-based gel-phase upon exposure to the aqueous tumor environment. This technique was first optimized to maximize distribution volume, using tissue-simulating phantoms. Then, chemically-induced epithelial tumors in the hamster cheek pouch were treated. As controls, pure ethanol injections of either four times or one-fourth the tumor volume induced complete regression of 33% and 0% of tumors, respectively. In contrast, ethyl cellulose-ethanol injections of one-fourth the tumor volume induced complete regression in 100% of tumors. These results contribute to proof-of-concept for enhanced ethanol ablation as a novel and effective alternative to surgery for tumor treatment, with relevance to resource-limited settings.
Collapse
|
11
|
Stuart-Shor EM, Cunningham E, Foradori L, Hutchinson E, Makwero M, Smith J, Kasozi J, Johnston EM, Khaki A, Vandervort E, Moshi F, Kerry VB. The Global Health Service Partnership: An Academic-Clinical Partnership to Build Nursing and Medical Capacity in Africa. Front Public Health 2017; 5:174. [PMID: 28791282 PMCID: PMC5522849 DOI: 10.3389/fpubh.2017.00174] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/03/2017] [Accepted: 06/29/2017] [Indexed: 12/02/2022] Open
Abstract
The World Health Organization estimates a global deficit of about 12.9 million skilled health professionals (midwives, nurses, and physicians) by 2035. These shortages limit the ability of countries, particularly resource-constrained countries, to deliver basic health care, to respond to emerging and more complex needs, and to teach, graduate, and retain their future health professionals—a vicious cycle that is perpetuated and has profound implications for health security. The Global Health Service Partnership (GHSP) is a unique collaboration between the Peace Corps, President’s Emergency Plan for AIDS Relief, Seed and host-country institutions, which aims to strengthen the breadth and quality of medical and nursing education and care delivery in places with dire shortages of health professionals. Nurse and physician educators are seconded to host institutions to serve as visiting faculty alongside their local colleagues. They serve for 1 year with many staying longer. Educational and clinical best practices are shared, emphasis is placed on integration of theory and practice across the academic–clinical domains and the teaching and learning environment is expanded to include implementation science and dissemination of locally tailored and sustainable practice innovations. In the first 3 years (2013–2016) GHSP placed 97 nurse and physician educators in three countries (Malawi, Tanzania, and Uganda). These educators have taught 454 courses and workshops to 8,321 trainees, faculty members, and practicing health professionals across the curriculum and in myriad specialties. Mixed-methods evaluation included key stakeholder interviews with host institution faculty and students who indicate that the addition of GHSP enhanced clinical teaching (quality and breadth) resulting in improved clinical skills, confidence, and ability to connect theory to practice and critical thinking. The outputs and outcomes from four exemplars which focus on the translation of evidence to practice through implementation science are included. Findings from the first 3 years of GHSP suggest that an innovative, locally tailored and culturally appropriate multi-country academic–clinical partnership program that addresses national health priorities is feasible and generated new knowledge and best practices relevant to capacity building for nursing and medical education. This in turn has implications for improving the health of populations who suffer a disproportionate burden of global disease.
Collapse
Affiliation(s)
- Eileen M Stuart-Shor
- Seed Global Health, Boston, MA, United States.,Department of Anesthesia and Critical Care, Beth Israel Deaconess Medical Center, Boston, MA, United States.,College of Nursing and Health Sciences, University of Massachusetts Boston, Boston, MA, United States
| | | | | | - Elizabeth Hutchinson
- Seed Global Health, Boston, MA, United States.,Department of Family Medicine, Swedish Family Medicine-First Hill, University of Washington, Seattle, WA, United States
| | - Martha Makwero
- Department of Family Medicine, University of Malawi College of Medicine, Blantyre, Malawi
| | - Jill Smith
- Seed Global Health, Boston, MA, United States
| | - Jane Kasozi
- School of Nursing, Mbarara University of Science and Technology, Mbarara, Uganda
| | - Esther M Johnston
- Seed Global Health, Boston, MA, United States.,Wright Center National Family Medicine Residency at HealthPoint, Auburn, WA, United States
| | - Aliasgar Khaki
- Department of Medicine, Herbert Kairuki Memorial University, College of Medicine, Dar es Salaam, Tanzania
| | - Elisa Vandervort
- School of Nursing, University of Utah, Salt Lake City, UT, United States.,Grounds for Health, Williston, VT, United States
| | - Fabiola Moshi
- School of Nursing, University of Dodoma, Dodoma, Tanzania
| | - Vanessa B Kerry
- Seed Global Health, Boston, MA, United States.,Mass General Global Health, Massachusetts General Hospital, Boston, MA, United States.,Department of Medicine, Massachusetts General Hospital, Boston, MA, United States.,Department of Global Health and Social Medicine, Harvard Medical School, Boston, MA, United States
| |
Collapse
|